Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,660.00    -30.00 (-0.53%)
Bid:
5,660.00
Ask:
5,670.00
Spread: 10.00 (0.177%)
Market Cap: £3.03b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director Appointments

23 Jun 2022 07:00

RNS Number : 8624P
Cranswick PLC
23 June 2022
 

23 June 2022

Cranswick plc(the "Company" or "the Group")

Director Appointments

Cranswick plc, a leading UK food producer, announces the appointment of Yetunde Hofmann as an independent Non-Executive Director of the Company and of Christopher Aldersley as an Executive Director of the Company, both with effect from 1 August 2022.

Yetunde Hofmann

Yetunde is the Managing Director of Synchrony Development Consulting, an international leadership and change consultancy that partners with leaders to facilitate strategy, change, diversity and inclusion and the founder of Solaris Global Executive Leadership Development. She is also a Trustee at the Institute of Business Ethics (IBE) and is a visiting fellow at the University of Reading's Henley Business School of Marketing and Reputation.

On appointment, Yetunde will become a member of the Audit, Remuneration, Nomination and ESG committees.

Yetunde is an independent Non-Executive Director at Treatt plc. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Yetunde Hofmann's appointment as a Non-Executive Director of the Company.

Christopher Aldersley

Chris joined Cranswick in 1998 and since then has undertaken a variety of senior management roles, becoming the Group's Chief Operating Officer in 2015. Chris has responsibility for managing the operations at the Group's four primary processing and sixteen added value facilities and also for its agricultural operations, which support the Group's vertically integrated supply chain strategy.

The appointment of Chris to the Board recognises his contribution to the Group and central importance of his role going forward as a member of the Board to the delivery of the Group's long-term strategy.

On appointment, Chris will become a member of the ESG committee.

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Chris Aldersley's appointment as an Executive Director of the Company.

Tim Smith, Chairman of Cranswick plc, commented:

"I am delighted that Yetunde and Chris will join our Board.

"Yetunde's experience will complement our existing Board. She has an established track record of mentoring and developing performance, talent and leadership strategies across a range of organisations, which will be invaluable to Cranswick.

"Chris's role at Cranswick has grown with the rapid development of the Group and he has been central to facing the challenges presented in recent times by Brexit and the COVID-19 pandemic. Chris helps deliver our Second Nature sustainability strategy. I am pleased his contribution is recognised with his appointment to the Board.".

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Nick Hayns/Chloe Retief

cranswick@powerscourt-group.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEERTIFFIF
Date   Source Headline
2nd Aug 201212:13 pmRNSResult of AGM
2nd Aug 201212:08 pmRNSTotal Voting Rights
1st Aug 20127:00 amRNSInterim Management Statement
11th Jul 20122:20 pmRNSDividend Timetable
10th Jul 201210:26 amRNSHolding(s) in Company
9th Jul 201211:29 amRNSHolding(s) in Company
3rd Jul 201210:28 amRNSTotal Voting Rights
2nd Jul 20127:00 amRNSAcquisition
20th Jun 201210:08 amRNSDirector/PDMR Shareholding
18th Jun 201211:18 amRNSDirector/PDMR Shareholding
1st Jun 201210:26 amRNSTotal Voting Rights
21st May 20127:00 amRNSFinal Results
2nd Apr 201211:38 amRNSTotal Voting Rights
30th Mar 20127:00 amRNSFourth Quarter Trading Statement
2nd Feb 20122:38 pmRNSDirector/PDMR Shareholding
30th Jan 20124:07 pmRNSDirector/PDMR Shareholding
30th Jan 20124:06 pmRNSDirector/PDMR Shareholding
30th Jan 20124:03 pmRNSDirector/PDMR Shareholding
30th Jan 20127:00 amRNSQ3 Interim Management Statement
13th Jan 201212:18 pmRNSAdditional Listing
8th Dec 201111:36 amRNSDividend Timetable
14th Nov 20117:00 amRNSHalf Yearly Report
6th Oct 20117:00 amRNSTrading Statement
5th Oct 20119:46 amRNSBlocklisting Interim Review
23rd Sep 20116:11 pmRNSClose period repurchase agreement
23rd Sep 20116:04 pmRNSTransaction in Own Shares
6th Sep 20114:27 pmRNSDirector/PDMR Shareholding
6th Sep 20114:27 pmRNSDirector/PDMR Shareholding
22nd Aug 20114:22 pmRNSAdditional Listing
2nd Aug 20114:07 pmRNSResult of AGM
2nd Aug 201112:27 pmRNSTotal Voting Rights
28th Jul 20115:17 pmRNSDirector/PDMR Shareholding
27th Jul 20112:54 pmRNSHolding(s) in Company
26th Jul 20117:00 amRNSInterim Management Statement
30th Jun 20114:40 pmRNSTotal Voting Rights
24th May 20112:31 pmRNSDirector/PDMR Shareholding
23rd May 20114:05 pmRNSHolding(s) in Company
16th May 20117:00 amRNSFinal Results
4th May 20118:56 amRNSTotal Voting Rights
4th Apr 20117:00 amRNSFourth quarter trading statement
31st Mar 20114:05 pmRNSTotal Voting Rights
31st Mar 20114:03 pmRNSBlocklisting Interim Review
22nd Feb 20117:00 amRNSAppointment of Joint Broker
1st Feb 20117:00 amRNSInterim Management Statement
21st Jan 20113:55 pmRNSDirector/PDMR Shareholding
21st Jan 20113:54 pmRNSDirector/PDMR Shareholding
21st Jan 20113:53 pmRNSDirector/PDMR Shareholding
20th Jan 20111:58 pmRNSAdditional Listing
7th Jan 20114:58 pmRNSTotal Voting Rights
9th Dec 20107:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.